期刊文献+

注射用雷贝拉唑钠的制备及安全性评价 被引量:4

Preparation of Rabeprazole Sodium for Injection and Its Animal Test on Safty
原文传递
导出
摘要 目的筛选注射用雷贝拉唑钠处方及制备工艺,并对制剂的安全性进行评价。方法应用化学动力学原理考察雷贝拉唑钠降解规律;通过对pH、溶媒、金属离子、支撑剂、抗氧剂及活性炭用量等因素进行考察,筛选出最佳处方和工艺,并进行了血管刺激性、溶血及过敏试验。结果雷贝拉唑钠对碱度的敏感度最大,液体状态下需要调节pH11以上,并筛选得到合适的支撑剂、抗氧剂及活性炭的用量;制备的冻干粉针无血管刺激性、无溶血现象、无过敏反应。结论制备所得的制剂质量稳定,制备工艺简单可行,制备的制剂安全性好。 OBJECTIVES To chose the best prescription and prepare Rabeprazole Sodium for injection and investigate its safety. METHODS Several kinds of parameter were chosen to prepare lyophilized injection of Rabeprazole Sodium such as pH, solvent, Metal ions, excipient, antioxidant and activated carbon. The degradation pattern of Rabeprazole Sodium and its effects were measured. At the same time, Irritative, anaphylaxis and haemolyticus tests were performed to evaluate the injectable safety of Rabeprazole Sodium for injection. RESULTS The pH of the solution should be adjusted above 11 and append a little antioxidant. The preparation had no hemolysis phenomenon, no significant irritation effect on vessels and no allergic response. CONCLUSIONS The technics of preparing Rabeprazole Sodium for injection is simple. The animal tests on safety is up to grade and the preparetion is stabilize.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第5期385-387,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 雷贝拉唑钠 冷冻干燥 制剂安全性 稳定性 pharmaceutics Rabeprazole Sodium lyophillization drug safty
  • 相关文献

参考文献8

  • 1李杰.波力特[J].中国新药杂志,2001,10(8):623-624. 被引量:6
  • 2MINER P, KATZ P O, CHEN Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole: a five-way crossover study [J]. Am J Gastroenterol, 2003,98 (12) :2616-2620.
  • 3冯春玲,郭宪清,吕焕菊.雷贝拉唑的临床应用[J].黑龙江医学,2004,28(1):61-62. 被引量:5
  • 4National standard (YBH 11012004) [S].
  • 5裴晓丽,刘明月,张小山,贾海英,李灵芝,白晓军.HPLC测定雷贝拉唑钠原料的含量及有关物质[J].中国药学杂志,2004,39(8):631-631. 被引量:9
  • 6TU X D, ZHANG J S, ZHU J B. Pharmaceutics [M].3rd. Beijing: People's Medical Publishing House. 2004:314-321.
  • 7Ch.P(2005)Vol Ⅱ(中国药典2005年版.二部)[S].2005.
  • 8SFDA, Guidance Documents for INDs [S]. 2005: 243-256.

二级参考文献5

  • 1[1]Dekk C P,Beker J A,Thjjodleifsson B,et al.Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer:a European multicentre study[J].Aliment Pharmacol Ther,1999,2(13):179~186.
  • 2[2]Langtry H D,Markham A.Rabeprazole:a review of its use in acidrelated gastrointestinal disorders[J].Drugs,1999,58(4):725~742.
  • 3[3]Vander Hulst R W M,Keller J J,Rauws E A J,et al.Treatment of helicobacter phlori infection:a review of the literature[J].Helicobacter,1996,1(1);6.
  • 4[5]Prakash A,Faulds D.Rabeprazole[J].Drugs,1998,55(2):261~268.
  • 5夏志伟,朱淑梅,段丽萍,常虹.质子泵抑制剂对根除幽门螺杆菌治疗的影响[J].北京医科大学学报,1999,31(1):74-75. 被引量:11

共引文献47

同被引文献21

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部